LLY — Eli Lilly & Company COM

Ownership history in ORBIMED ADVISORS LLC  ·  58 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in Eli Lilly & Company COM (LLY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.36% (2001 Q3)
Avg. % of fund
3.36%
First filed
2001 Q2
Last filed
2025 Q4
Quarters held
58
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 301,200 — 0% 6.61% $323.7M $1072.89
2025 Q3 REDUCED 301,200 -36,400 -10.8% 5.40% $229.8M $760.61
2025 Q2 UNCHANGED 337,600 — 0% 6.57% $263.2M $775.39
2025 Q1 UNCHANGED 337,600 — 0% 6.65% $278.8M $819.84
54 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LLY price (monthly, adj. close)

Other funds also holding LLY

As of 2025 Q4 — sorted by position size

LILLY ENDOWMENT INC 3Y 7Y 100.0% Private Capital Advisors, Inc. 3Y 7Y 46.91% XR Securities LLC 3Y 7Y 41.84% Bedel Financial Consulting, Inc. 3Y 7Y 37.93% PNC FINANCIAL SERVICES GROUP, INC. 3Y 7Y 30.13% Goelzer Investment Management, Inc. 3Y 7Y 27.06% Holistic Financial Partners 3Y 7Y 26.45% Cascade Financial Partners, LLC 25.78% SAPIENT CAPITAL LLC 22.72% WEATHERLY ASSET MANAGEMENT L. P. 3Y 7Y 22.67%
← Back to ORBIMED ADVISORS LLC Holdings